Hospitalized Older Patients with Clostridioides difficile Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant | Zendy

Jae Hyun Shin | Zendy; R. Ann Hays | Zendy; Cirle A. Warren | Zendy

Open Access

Hospitalized Older Patients with Clostridioides difficile Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant

Author(s) -

Jae Hyun Shin,

R. Ann Hays,

Cirle A. Warren

Publication year - 2021

Publication title -

advances in geriatric medicine and research

Language(s) - English

Resource type - Journals

ISSN - 2632-9921

DOI - 10.20900/agmr20210012

Subject(s) - medicine , refractory (planetary science) , clostridioides , pseudomembranous colitis , clostridium difficile , fecal bacteriotherapy , population , surgery , antibiotics , gastroenterology , physics , environmental health , astrobiology , microbiology and biotechnology , biology

Options for Clostridioides difficile infection (CDI) refractory to conventional therapy are limited. Fecal microbiota transplant (FMT) is considered safe and effective treatment for recurrent CDI and could be a treatment option for refractory CDI. We investigated the efficacy and safety of FMT in hospitalized patients who were not responding to standard treatments for CDI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research